HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pandemic Makes OTC Access To Daily Oral Contraceptives More Critical, Experts Tell FDA

Executive Summary

Nearly 120 researchers, clinicians and advocacy groups have signed a letter to be sent in late August urging FDA to prioritize completion of a review process to make oral contraceptives available OTC.

You may also be interested in...



Private Label OTC Giant Stretches For Switch Help

HRA brings needed expertise in OTC switches to Perrigo, which regularly is first to launch generic equivalents for brand switches but its name hasn’t been linked to submitting proposals for making additional drug ingredients available OTC.

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 

Sun Pharma US Business Co-packages OTC Emergency Contraceptive With Pregnancy Test

My After Plan has been available online and in stores since October 2020, shortly before Sun Pharma received registration for the trademark in the US. Recently, marketing and design consultants announced their work for Sun Pharma's Ohm Labs on My After Plan packaging.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel